Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hi mad
I like where you're going in your thinking. Assuming the trial data and science of BIEL holds up after years of work, it would do a lot for the credibility of FDA for folks there to simply review and approve devices that allow for drug-free, side-effect free pain management. The world now knows the technology works, Boots is the largest pharma retailer in the world! What's the downside to us no longer looking foolish here? Zero!
Suggest you pay attention to the wisdom of steelyeye fuente and all others might consider it too. . . .
And the answer to your question on BIEL valuation steelyeye is 'no' it is not appropriately priced for a game-changer, but that is and will continue to change. For drug-free, no side effect pain management for joints, muscles and menstrual cramps, are you kidding me?
I don't profess to know anything about valuation in these circumstances, so I yield to others more knowledgeable.
Ha - you're right bieliever - can't fault mad though, he was trying to get credible info for us all during difficult times and shared what he got. We have all praised him, which we should - and congrats to the poster who was big enough to admit he fired without aiming on madp.
madp is back but his birdie's legs are in the air!
Hear, hear mad - all well said, we owe fuente for his knowledge.
Lemme know how many shares you buy fuente - you are far to knowledgeable of what this FDA announcement means to BIEL to ignore it. You were a shareholder when things were bleak for the company and it was stumbling over its ineptitude. Poor applications, poor scientific and trial data, alienating the FDA by marketing in the US without regulatory approval - couldn't get any worse!
Now, company has survived, diluted like crazy to keep the lights on and the FDA announces a capitulation to now create a new device category which BIEL products will be part of if their application is approved? The company has involved a number of professionals to assist process and you are not back in? Makes no sense. Only a fool doesn't change his mind.
Bottom line is BIEL products represent the opportunity for US pain sufferers to have effective pain management with a patented, made in the USA, safe, efficacious drug-free device. And not many people are talking about ALLAY, the BIEL product for menstrual pain suffered by tens of millions of US women.
Am I pro BIEL? Yes. I used ActiPatch a few years ago on a mother of all ankle sprains and went from black and blue with crutches, worse than a break to walking no problem in a few days to the amazement of my Doc. He couldn't believe it! And Pro sports team are now using it? And you're not getting back in? Makes no sense.
Amazing article authored by a man who tells his story in a straightforward way (excuse the pun :) )
http://seekingalpha.com/instablog/19429361-out-of-the-box/2669901-my-accidental-medical-discovery-benefit-for-ed-with-a-bioelectronics-product
Is this serendipity staring us in the face? It's not uncommon in the pharma medical field. If so, Boots in the UK will be out of stock for months as BIEL displaces Cialis and Viagra in the bedroom. Walgreens should be buying BIEL stock.
Hey Sup
I suspect fuente will get back in - he knows what's what and thanks to him for the intel. I see the announcement as quite simply the FDA listened to a number of parties, 1 of them being BIEL, who revealed that FDA needed a new class for these medical devices. I read the minutes of the FDA called public meeting by the Medical Devices Advisory Comm and it seemed positive.
Thje FDA has now made its decision - to create a new classification which would be a home for receiving applications for products including BIEL devices. Who cares if it takes 90 days or 150 days, big deal. The only issue is BIEL is alive not dead in the water and the door is open for it to make application to have its devices approved for OTC sales here in the US. Drug free pain management with zero side effects - if that is not a disruptive event, I don't know what is.
Now we move to something I posted on over a year ago - should big pharma not be seriously looking at BIEL? I also wrote a while ago that the new CEO of J&J (I think it was J&J) was previously Director of its devices division. Stranger things have happened and it's a new day at BIEL, no one can refute that!
Soooo, we now know ddls was one of perhaps few who cut off emails from company, shouldn't be difficult to narrow that down . . . . just sayin
Other good guys here are better able to comment, but my sense is that the reclassification allows the door to open for BIEL - they then re-apply for OTC consideration under nuclass.
One must not forget that when BIEL got a clear 'no' on its app for OTC approval from the FDA, which was presumably ticked off because BIEL was marketing in the US without FDA approval, BIEL management then appealed to the FDA Gods. Some of this is speculation since the FDA should not be influenced against an applicant, but the world is political. BIEL tenacity and that of other companies applying for OTC approval for their devices may have (likely?) contributed to the FDA calling the public meeting to hear out the various sides. The minutes of that hearing were positive IMO - and here we are.
Facts are that BIEL products effectively manage pain. That helps reduce user stress, which helps to promote faster healing in itself and there are no negative side-effects. It is also a new treatment space and these things take time. Think you're right, by having an approval process may lead to a huge run on stock. BIEL advantage is they have numerous studies and trials which should be a good thing. Over to my fellow posters who know the process better than I.
Hey fuente and all good guys - you know who you are.
This started for me with a badly sprained ankle, black & blue.
College buddy in Canada sent me 3 ActiPatch - amazing results. My Doc couldn't believe what he saw.
Bought stock, watched downturn. FDA slaps BIEL wrist for promoting in US. BIEL fault as idiots were jumping the FDA gun.
Numerous fine shareholders post here despite incessant bashing by a few, which didn't change the fact that ActiPatch works.
We all slammed FDA for delays in seeing that BIEL has patented, drug-free pain management products with zero side-effects. Tylenol and other approved drugs continue to harm.
Public hearings in 2013 called by FDA, positive.
Now FDA releases about re-class. They move slowly but are big enough to continue assessment, which is their mandate.
If we dare to state that there has now been a game-changing breakthrough at FDA in favor of BIEL, what does that say?
Market is determining that and the system seems to work, late, but works.
I'm sore that Canada kicks our butts in men's and women's hockey and curling in Sochi - all gold and we are still way behind Canada and UK on BIEL approvals on a simple drug-free pain solution with no side effects? How does this happen and what should we do to catch up? Makes me wonder what else we are falling short on.
Good for you.
Go BIEL
Mary - thank you, I will, do I have a choice? :)
Hi Mary
I only say "good news today" when I see it.....
I do know the I like BIEL's products because I have personally used ActiPatch
- amazingly efficacious
- totally drug-free
- zero side-effects
- OTC permitted in most of the free world, except here in the USA
Those are all facts....
Am I hopeful there will be good news today, tomorrow and next week and month for BIEL? You betcha.
Can you elaborate on what seems to be your certainty for today?
Thanks very much
No, I did not sell shares at .12 as claimed and I invite a wager, my assets against yours, feel lucky?
1st post of yours I've seen in weeks. Can't dispute your opinion, nor you mine. If BIEL goes to 25 cents or more because it has products that work unbelievably well, drug-free pain relief, with no side-effects ever, FDA approval and growing sales, I will be happy, very happy.
If it goes to zero, I won't care much, except a company was denied FDA approval for OTC sales in the USA, unlike the rest of the free world granting it open approval - UK, Canada etc.....
Anyone touting the products for great things is a bieliever - anyone being hyper-critical without reason has an ulterior motive, bitterness? Would love to have your opinion as to relative motives.
As Mary said, stay positive. Positivity promotes positive physical and emotional health and well being - Negativity promotes poor physical and emotion health and well-being. Do you agree? Thanks
Purchase of 30 Million + shares - lucky buyers!!!
Thanks for your informative post at 31605 bieliever!
you echo the sentiments of many Casper.
Well done
Greeting and hope you're well.
Hopefully management, new or old, will create sales and cash flow to enable the company to do the necessary audits and uplist to a real exchange, otherwise the broker/feeders will just continue to make pennies, but real % moves where they currently are. Certainly shareholders aren't making it! And, therefor, neither is management, making it a poor exit strategy for them.....
A new player with money may change that.
I have spoken at length with 2 close business acquaintances - one a conventional broker here in NYC and the other a partner in a substantial Wealth Management firm in Boston - they both say that until the company builds such that it can relocate to a different trading venue the price will undoubtedly remain depressed. Can't wait for a move to the NASDAQ OTC:BB. GO BIEL!
Hey disciple - elated to see your message on where things are with BIEL - and your opinions, which is what makes iHub work!
Philosophically iHub intelligently allows one to have a poster on ignore - have the other poster on ignore which is allowed under the rules and saves me a lot of time and head shaking about a disgruntled ex-employee/consultant who is bitter. Nothing else is driving those hundreds of messages except time on his hands.
I, like many others believe in the BIEL product line and even that Whelan may have learned lessons of what not to do as time has gone by. I agree, sales are the name of the game. I also liked the latest intervies with Dr. Dumas, who is definitely a pro, and the Benelux announcement. Go BIEL
Hey hooker and fuj
you are both on the bulls-eye with your recovery stories.
As you both have probably read, I badly sprained an ankle playing tennis - X-ray for a fracture etc.
An old college classmate and tennis player up in Toronto recommended ActiPatch and I tried it.
Amazing, no other word for it, my doc couldn't believe the recovery from totally black and blue and on crutches and pain-free. It was stiff and I had to do stretching to get the range of motion back but my doc said I should have been off it for a few weeks, as bad as a break.
There is no rational dealing with an old disgruntled employee....
That's why I use the ignore facility of iHub, helps to make the site what it is, a place where reasonable people can chat and exchange ideas.
I have asked the question before - hundreds of millions of shares sold by dilution - I get that need in order to pay the bills.
But who is buying those shares? And given that the company has patented devices for drug-free pain relief and no side effects, why does the price stay in the toilet? OTC drugs for pain are killing Americans and BIEL has solutions, makes no sense.
And fuj, don't forget, ddls, along with most other shareholders is still really pi--ed off at management for the way the regulatory process and financial affairs have been handled - can't say I fault him there, but I also don't know enough to cast aspersions,
BUT ddls does know the products and has never once refuted that they are free of side-effects because all the trial data confirms that claim, thanks ddls.
And that is why the FDA stance for the past 3 or 4 years is so perplexing. It's almost like saying contaminant free water should not be consumed! Drug-free pain relief with no side-effects?
Nonsense not to fasttrack BIEL products and others in the same space to approval! The FDA represents the American people, not big pharma, that's why it has always seemed too risky to me for anyone at the FDA to play stupid games, not worth risking a career over, or jail, or both. And, can you imagine the multi-Billion dollar fines and jail terms to any big pharma execs who played such games as undue influence these days? They are not so stupid either, they are very bright. Much, much less expensive for them to acquire BIEL and create a sales division for this space and make money than play games and with zero risk too!
ddls is my guy too and I'm following his recommendation - he should know, he worked for the firm and knows the products intimately - thanks ddls
I agree Johny - if BIEL can hang in, even if it has to dilute to stay alive, big pharma should be worried. Pain relief with ActiPatch and the rest of the products, especially for women each and every month with ALLAY? Drug free and no side effects, are you kidding me? I have hung in with BIEL despite management and FDA issues because I see it in the same camp as the 100 mpg and 200 mpg carbs we all heard about big motors and big oil buying and shelving. BIEL will be bad for big pharma, plain and simple.
If you're correct about $12+, it will be because of a substantial breakthrough with the FDA which still has to absorb the data from the public meeting and report, I think. The minutes of the meeting looked positive and fair, so we will see. If it's conclusion is positive I will buy all the way up because the news will push it higher. That's the only way I see BIEL at 20 cents as ddls touts, sorry.
He worked for BIEL
I love your positive style, please keep posting, as you do.
I also try, as you do, to stay on topic and stick with the business issues and challenges facing BIEL as a publicly traded company struggling to get traction.
Yes, management has lacked in several areas, but they are, or will, see the light out of necessity or desperation or both. They must do whatever it takes to comply with regulatory requirements, anything else, like fighting city hall, would be continued stupidity.
The actualization of the BIEL bundle, especially the big players, ActiPatch and ALLAY, is simple - all products work well, drug-free and no negative side-effects. Who else can say that.
So, when management continues its obviously changed attitude of compliance, rather than stubbornness, BIEL will be successful and investors will win. Keep posting edbi, your contribution is huge and thank you.
Cakemix - Good luck with the Achilles - I'm sure ActiPatch will help pre and post-Op. Main thing is get well and best wishes for a speedy recoveryRX :)
Like your last point a lot bieliever.
It is indeed a shame that people in our country who are suffering from long term ailments, or periodic pain and cramping in the case of potential ALLAY users, cannot even access ActiPatch or ALLAY legally in order to get drug-free, side-effect free relief.
From the minutes of the May 10 FDA hosted meeting I read, things seemed very professional and positive.
Hey Fuj - hope you're well.
I have the other side of this argument on ignore - life is much more peaceful that way without the diatribe.
Purely on the business issues, product is highly efficacious, from personal use. No side effects, personal use, along with numerous studies and trials.
Management 'seems' much better. Company is financing itself and its' further studies by blowing out shares and dilution - called survival.
FDA held a public meeting, I read the entire minutes, and we are waiting. With the US market and the ripple effect if BIEL gets FDA approval, I m still positive that we will enjoy a multi-bagger, hopeful only, not a fact. With some stating "facts", they reveal themselves, a good thing, don't you think?
Hey Sausage,
I agree on a number of points and $10 per is a lot less than $50, but I strongly suspect there is much more margin then you outline. Cost of goods is not a lot and packaging and O/H lessens as an overall percentage when things start to happen. But you're right - it's the business model and management. The executives seem more focused and less shoot-from-the-hip, so hopefully the FDA will start to 'get it'.
Bottom line? US market, drug-free, pain relief with no side-effects, in the case of both ActiPatch and ALLAY. The size of the latter market in amazing and what a relief for long-suffering women.
A buy=out would be sensible, don't know if current ego will permit, only a fool doesn't change his mind......
Your message brings a smile and I now know all is well in the world and there are great things ahead for BIEL with your involvement as it is. Thank you
How about 1.9/share ddls?
The products work beautifully - do exactly what is touted and without any side-effects.
Imagine! Drug free pain relief, with absolutely no side effects.
Hah - good post edbi
To you, may and finish - Don't forget Lost & Found
Any naysayers investing if and when an FDA approval for OTC retail sales of BIEL products happens will be sending flowers to the company
Last I saw here was a picture of Steve with a vehicle in Florida working with BIEL - please forgive my tongue-in-cheek comment - just seems that Steve had a lot on the ball in his hundreds of posts here and hopefully new appointee Dr. Dumas has the same.
Hey sausage - I'm skeptical about everything on BIEL until I see results, That is not to say I am not totally positive on ActiPatch and ALLAY because I am. I've used the former on an ankle and it was amazing. I think management is on a better course, but the previous direction was poor.
I know of no reason why they should not get Class II OTC approval and many why they should.
If you mean north of the border in Canada, no idea, I'm in NYC but I did see a piece in the WSJ yesterday that a large food retailer has bought the Shoppers Drugmart chain for $12Billion. There was talk of BIEL going into Shoppers but I have no idea where that is, if anywhere.
I took the time to read the full report of the public meeting the FDA hosted and it seemed positive.
The recent appointment or 'engagement' described in today's press release of Dr. Christine Dumas as Spokesperson and Patient Advocate is also positive. Give the lady a truckload of stock options at 25 cents and let her go to it. Give her an office next to Steve so the synergy of two people who know what they are doing multiplies, along with the share price
Be glad there was not another zero - you would be burnt &X)#@